Double-Blind Randomized Controlled Trial of Toxin-Heat Syndrome Gastric Ulcer Treated by Xiao-Yong-Kui-De-Kang Granules
Liu Lin,Wang Chuijie,Zheng Hongxin,Zhou Xuewen,Li Huizhen,Shi Zhaohong,Dong Aimin,Yu Qinggong,Huang Yu,Jiang Wei,Bai Guang,Li Yufeng,Tang Lidong,Li Yan,Wang Hui,Ma Qianzhang
DOI: https://doi.org/10.3969/j.issn.1674-3849.2012.02.013
2012-01-01
Abstract:This study was aimed to clarify the therapeutic effect of Xiao-Yong-Kui-De-Kang Granules(XYKDKG) to gastric ulcer in active stage in order to prove that "toxin-heat" is the etiopathogenisis of the disease.Key points in syndrome differentiation of "toxin-heat" will be explained.A multi-center randomized control,double-blind and double dummy clinical trial was conducted.A total of 300 patients with gastric ulcer in active stage were selected with features of toxin-heat syndrome in traditional Chinese medicine(TCM).All patients were randomly divided into experiment group and control group.In the experiment group,150 patients were treated with XYKDKG,which is effective in heat-clearing,toxin-relieving,ulcer-reducing,and simulated Kui-Yang capsule(KYC).And in control group,the other 150 patients were treated with KYC and simulated XYKDKG.The double-blind and double dummy clinical trial was continued for 6 weeks.Then,main and secondary symptoms were observed to comprehensively determine the therapeutic effect with quantitative marking criterion.The statistical analysis showed that the clinical recovery rate was 45.1%(64/142) and the total effective rate was 99.3%(141/142) in the experiment group.In the control group,the clinical recovery rate was 6.9%(10/144) and the total effective rate was 91.0%(131/144).The comparison showed that the experimental group achieved better therapeutic effect than the control group(P< 0.01).In the improvement of each symptom,the experiment group is better than control group(P< 0.01).The comparison between post-treatment single symptom and baseline showed that the experiment group was better than the control group(P< 0.05).Furthermore,the experiment group received better effect than control group in relieving stomach burning pain symptom(P< 0.01) in 14 days,acid regurgitation(P< 0.01) in 14 days,impatience(P< 0.05) in 28 days,epigastric upset(P< 0.05) in 28 days,dry mouth(P< 0.01) in 28 days,bitter taste in the mouth(P< 0.01) in 28 days,tongue coating improving(P< 0.05) in 42 days.The score of each symptom pre-and post-treatment is improved in experiment group(P< 0.05).There was no significant statistical difference in pulse presentations pre-treatment,14-day medication,28-day medication and post-treatment in both groups(P> 0.05).It was concluded that XYKDKG had an obvious effect in improving symptoms of patients with gastric ulcer in the active stage than control.The therapeutic effect showed that "toxin-heat" is the etiopathogenisis of gastric ulcer in active stage.Key points in syndrome differentiation of toxin-heat syndrome of gastric ulcer are severe stomach burning pain,acid regurgitation,epigastric upset,dry mouth,bitter taste in the mouth,red tongue with yellow or greasy coating.The treatment principle is to clear heat,relieve toxin,and reduce ulcer to generate new tissues.